A randomized, phase II, multicenter, open-label study of trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing gastric cancer

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; p. ix65
Main Authors	Shitara, K., Bang, Y.-J., Sakai, D., Yasui, H., Kawaguchi, Y., Sugihara, M., Saito, K., Dalal, R., Yamaguchi, K.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.11.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy432.058